Alembic Pharmaceuticals Limited — Board Meeting, 05-08-2025: Outcome of Board Meeting

Alembic Pharmaceuticals' board met to approve its financial results for the quarter ended June 30, 2025. The company reported consolidated revenue from operations of Rs 1,710.72 Cr. Net profit for the period stood at Rs 154.38 Cr, with consolidated earnings per share (EPS) at Rs 7.85. The results were approved by the Board following review by statutory auditors.